Floatz logo

Cyclophosphamide

HER2/Neu Positive

University of NebraskaSmall moleculePhase 3Dormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
55/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the HER2/Neu Positive cohort.

Asset / SponsorPhaseRating
TRASTUZUMAB
Northwestern University
Phase 3BBB
Inno-206
University of Nebraska
Phase 3BB
Irinotecan
National Cancer Institute (NCI)
Phase 3BB
(+)-VINCRISTINE
National Cancer Institute (NCI)
Phase 3B
Epirubicin
National Cancer Institute (NCI)
Phase 3B

View all 22 →

Same molecule, other indications

Cyclophosphamide is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
mycosis fungoidesDormant
BBB
Indicative ·
78 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →